NCT00210626 – A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects Posted on January 12, 2017 by tsuperadmin -
Efficacy in the rHuEPO (Epoetin Alfa) in the Critically Ill Patient: A Randomized, Double Blind, Placebo-Controlled trial Posted on October 29, 2015 by tsuperadmin -
NCT00091910 – A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Epoetin Alfa in Critically Ill Subjects Posted on October 20, 2015 by tsuperadmin -
NCT00270283 – A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy Posted on October 20, 2015 by tsuperadmin -
NCT00270101 – A Placebo-Controlled Study on the Effect of r-huEPO in Patients With Multiple Myeloma Followed by an Open-Label Extension Posted on October 20, 2015 by tsuperadmin -
NCT00270049 – The Effect of Subcutaneous r-HuEPO in Patients With Chronic Lymphocytic Leukemia Posted on October 20, 2015 by tsuperadmin -
NCT00270166 – A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy Posted on October 20, 2015 by tsuperadmin -
NCT00270127 – Double-Blind, Placebo-Controlled Study to Assess the Effect of Early Intervention and/or Treatment With Epoetin Alfa on Anemia in Cancer Patients Receiving non-Platinum-Containing Chemotherapy Posted on October 20, 2015 by tsuperadmin -
NCT00211133 – A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Impact of Maintaining Hemoglobin Using Eprex (Epoetin Alfa) in Metastatic Breast Carcinoma Subjects Receiving Chemotherapy Posted on October 20, 2015 by tsuperadmin -
The YODA Project